Quantcast
Connect with us

Antibody injections could fight COVID-19 infections – an infectious disease expert explains the prospects

Published

on

Antibodies are part of us – literally.

We have billions of them in our bodies with a combined weight of about 100 grams, or about the weight of a bar of soap. If there are so many antibodies inside our bodies then they must be safe and very important, right?

Indeed, antibodies are perhaps the safest type of therapy and have many important functions. One of them is to protect and cure infections caused by viruses. The human immune system can produce antibodies specific for each type virus that bind strongly to the virus and block it from infecting our cells – so-called neutralizing antibodies.

ADVERTISEMENT

I am an infectious disease scientist and am interested in antibody therapeutics because they are a relatively safe way to prevent severe disease and save lives, particularly when a new, deadly virus emerges.

To stop the spread of COVID-19, billions of people will need to have antibodies to protect against the new coronavirus. So the question is how can we isolate and produce neutralizing antibodies in large enough quantities to serve everyone who needs them, including research laboratories and pharmaceutical companies?

What are antibodies?

Our immune system makes antibodies in response to a foreign pathogen, whether that be a bacterium, virus or fungi.

Antibodies are Y-shaped blood proteins made by white blood cells called “B cells.” They neutralize pathogens by attaching to their surface, blocking them from entering our cells and signaling our immune system to clear the pathogen from our bodies.

Humans have all sorts of different antibodies floating around inside us at any given time looking for foreign pathogens to attack. When a specific virus, such as SARS-CoV-2, infects our bodies, our immune system will try to produce enough specific antibodies against it before the infection becomes overwhelming.

ADVERTISEMENT

This process can happen faster and be more successful in preventing infection if we already have existing antibodies against the pathogen.

Scientists around the world are hunting for specific antibodies that can target SARS-CoV-2 and prevent it from infecting cells.
ALFRED PASIEKA/SCIENCE PHOTO LIBRARY / Getty Images

Finding antibodies to treat COVID-19

When I was in my native country of Bulgaria, I was fascinated with so-called hybridoma technology and used it to produce monoclonal antibodies (mAbs) – “mono” meaning “one,” or one defined antibody with known affinity for a specific pathogen. Later, at the National Institutes of Health, my team used a very powerful method called phage display to discover highly specific, potent human mAbs against many viruses, including SARS-CoV, MERS-CoV, and Hendra and Nipah viruses.

Now, at the University of Pittsburgh, we’ve discovered potent neutralizing mAbs against SARS-CoV-2 using phage display. We are conducting animal experiments now and expect to publish our results soon in a peer-reviewed journal. The sequence of the most effective and safe mAb will be provided to a company which will insert the gene that encodes the antibody into cells to produce large quantities of the antibody for studies in human clinical trials.

ADVERTISEMENT

There is also a method to extract B-cells from patients who survived SARS-CoV-2 infections, select the ones which produce the most effective specific antibodies and then grow those cells in cultures in the lab. These lab-grown B-cells then function as little factories to produce neutralizing mAbs. A recent study published in Science described the work of scientists from China who used this method to identify two such antibodies.

The Chinese researchers showed in an animal model of SARS-CoV-2 infection – in which mice were engineered with the human ACE2 receptor that enables the virus to infect cells – that these mAbs were effective at blocking the virus. Another paper published in Cell using the same model reported a similar finding.

ADVERTISEMENT

Other published reports have described neutralizing SARS-CoV-2 mAbs but without evaluation in animal models.

Why are animal models so important? Because there are many other factors that could affect antibody efficacy in a living organism that can’t be simulated in a petri dish. For example, how long are mAbs functional in the body and are they safe? Animal models can provide preliminary safety data. Beyond animal models, a key mAb property to consider is whether it can be efficiently manufactured in a stable, safe form for human use.

Based on the published studies I mentioned, media reports, the generally favorable attributes of antibodies and my own experience, I believe mAbs to SARS-CoV-2 will be approved this year for prevention and treatment of COVID-19.

ADVERTISEMENT

[You need to understand the coronavirus pandemic, and we can help. Read The Conversation’s newsletter.]The Conversation

Dimiter Stanchev Dimitrov, Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh

This article is republished from The Conversation under a Creative Commons license. Read the original article.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Experts say coronavirus is spreading through ‘airborne transmission’ — and there could be major implications

Published

on

The World Health Organization was warned in an open letter sent by 239 scientists from 32 countries that COVID-19 is being spread through airborne transmission, The New York Times reported Saturday.

"If airborne transmission is a significant factor in the pandemic, especially in crowded spaces with poor ventilation, the consequences for containment will be significant. Masks may be needed indoors, even in socially distant settings. Health care workers may need N95 masks that filter out even the smallest respiratory droplets as they care for coronavirus patients," the newspaper explained. "Ventilation systems in schools, nursing homes, residences and businesses may need to minimize recirculating air and add powerful new filters. Ultraviolet lights may be needed to kill viral particles floating in tiny droplets indoors."

Continue Reading

2020 Election

Montana GOP ticket sidelined after exposure to COVID-positive Trump, Jr. girlfriend Kimberly Guilfoyle: report

Published

on

The Montana Republican Party is facing a crisis after multiple members of the ticket were potentially exposed to COVID-19.

"Montana gubernatorial candidate Rep. Greg Gianforte and his running mate, Kristen Juras, confirmed Saturday they will self-quarantine after Gianforte's wife, Susan, and Juras attended an event last week with Kimberly Guilfoyle, who has since tested positive for COVID-19," KBZK-TV reported Saturday.

Gianforte is currently Montana's lone congressional representative. He is not running for reelection as he's running for governor. In June, the Montana GOP nominated State Auditor Matt Rosendale to replace him.

Continue Reading
 

Breaking Banner

WATCH: Florida beachgoer pushes new conspiracy theory of how COVID-19 got to the United States

Published

on

On Saturday, a viral video showed Jacksonville, Florida attorney Dan Uhlfelder — famous for touring Florida's beaches in a Grim Reaper costume to protest lax COVID-19 safeguards — confronting a beachgoer.

The other man offered a novel conspiracy theory of how the virus spread to the United States: that former Vice President Joe Biden and his son Hunter were behind the whole thing.

"Biden and Hunter went over to China, and then brought it back," said the man.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image